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Abstract: Primary spinal giant cell tumor (PSGCT) considered as rare primary 
neoplasm, with predilection for subarticular location and commonly located at knee 
joint region, sacrum or distal radius, however, spinal involvent is uncommon and 
comparatively much rarer in the cervical spine. Further occurrence of giant cell tumor 
in the Axis vertebra is extremely uncommon and easily misdiagnosed and, thus, 
treatment is still debated and various treatment modalities and different surgical 
approaches were utilized during evolution of surgical management. Authors could 
collect only 14 cases of primary giant cell tumor affecting Axis vertebra in a detailed 
Pubmed and Medline search, out of which 12 cases were primary and rest two case was 
recurrent. So authors reviewed in total thirteen cases primary giant cell tumor of Axis 
managed surgically, including our case. Out of 13 PSGCT, twelve cases were managed 
with surgical resection and the rest one case was managed with monoclonal antibody 
using Denosomab monotherapy without any surgical intervention. In the surgical group 
(n=12), nine cases had two staged surgical procedure, first being posterior fixation 
followed by anterior approach with resection of tumor while, the rest three had one stage 
surgical resection including current case. Authors reports a unique case of spinal giant 
cell tumor developing in a- 38 - year male with history of renal transplant , presented 
with neck pain and difficulty in walking, neuroimaging revealed a osteolytic mass lesion 
involving body of axis vertebra with extension into right sided lamina , underwent two 
stage complete surgical intervention. Authors describes management of such rare locally 
recurring primary bony pathology affecting axis vertebra as it is not only interesting and 
challenging and different management modalities, various, surgical approaches and 
issue of renal osteodystrophy along with pertinent literature is also reviewed briefly.  
Key words: Spinal giant cell tumor of axis vertebra, surgical management, two stage 
treatment, renal osteodystrophy, management 
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Introduction 
The first description of giant cell tumour 
was put forward by Cooper and Travers in 
1918. (1) The "Giant cell tumor” term was 
coined by Bloodgood in 1919. (2) PSGCT 
location represent extremely uncommon 
location, constitute about 5-15 % of all G CT. 
(3, 4, 5) In PSGCT, vertebral body is more 
commonly involved compared to the posterior 
vertebral elements (6, 7). The management of 
GCT is controversial due to its rarity of 
occurrence and associated unpredictable 
behavior. (2-6) In 1940, Jaffe et al. (3) made an 
attempt to clearly define the definitive 
patological basis for classifying and 
differentiating giant cell tumor from similar 
lesions eg. aneurysmal bone cyst, 
chondrosarcoma, chondro­ myxoma and non-
osteogenic fibroma of bone. However, a wide 
local surgical excision must include adjacent 
surrounding normal tissue whenever feasible.  
Case illustration  
A 38 –year male presented with complaints 
of neck pain for last six months, insidious in 
onset, which used to get worsened in sitting 
position and during walking, used to support 
his head and neck by hand which associated 
with restriction of neck movement. His 
significant past medical history included renal 
transplant in December 2007, at our institute 
for end stage chronic kidney disease secondary 
to chronic glomerulo-nephritis associated 
vasculitis. He was getting regular follow-up 
with nephrologist and transplant surgery OPD 
clinic and he was advised to continue 
medication including, tablet prednisolone 
5mg daily, capsule tacrolimus 3.5 mg twice a 
day, along with antihypertensive medications 
in addition to injection erythropoietin 100 
mcg subcutaneous every three week and iron 
and folic acid supplementation. In March 
2008, had graft dysfunction, graft biopsy was 
suggestive of antibody mediated rejection with 
evidence of transplant glomerulopathy. He 
also suffered cytomegalovirus colitis in 2013.  
Routine serum biochemistry revealed 
blood urea 53 mg/dl and serum creatinine 2.4 
mg/dl, while the rest of biochemistry and 
hemogram were within normal limit. Non-
contrast craniovertebral junction computed 
tomography revealed evidence of osteolytic 
lesion of axis affecting the second cervical 
vertebra causing expansion of the body with 
presence of septation and also extending into 
right side lamina, cortical breach observed on 
antero-inferior aspect, causing compromise of 
the spinal canal with secondary cervical canal 
stenosis. (Figures 1, 2, 3) 
Magnetic resonance imaging of 
craniovertebral junction, sagittal section 
image demonstrated presence of 
heterogeneous signal intensity mass lesion 
affecting vertebral body of axis, measuring 36 
x 30 x 22 mm in size, (Figures 4 and 5 a, b) 
causing expansion and destructive the 
vertebral body and also further extending to 
involving lamina and producing significant 
mass effect in form of obliteration and 
indentation of anterior thecal sac and spinal 
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cord indentation as well as displacement at 
same level. As he had slightly deranged renal 
function, planned for two stage surgical 
excision to avoid further renal function 
compromise.  
First stage planned was radical 
decompression, obtaining specimen for 
histopathological confirmation and posterior 
occipitocervical fixation and followed by 
transoral decompression after first surgery 
depending on renal functional status in the 
second stage surgery, as deranged renal 
function precluded prolonged surgery for 
combined anterior and posterior approach in 
a single setting. After anaesthesia clearance, he 
was taken up for surgery under strict guidance 
and supervision of nephrologist. He was and 
taken up for surgery in the prone position. An 
skin incision from inion to C5 level was given, 
further dissection was carried out along 
ligamentum nuchae and Occipital bone, C1 to 
C4 lamina were exposed. The anterior arch of 
C1 was removed, laminectomy of C2 and C3 
were carried out. The right lamina showed 
presence of soft, grayish yellow, moderately 
vascular mass. The c2 body was entered and 
gross total microsurgical decompression was 
carried out under, however, the part of the 
lesion located central part of Axis vertebra was 
not accessible. After securing hemostasis, 
posterior occipitocervical fusion was carried 
out with occipital plate and lateral mass screw 
fixation of C3 and C4 level. He tolerated 
surgical procedure well with no fresh 
neurological worsening or any renal 
parameters derangement in the post-operative 
period. X-ray showed implant in proper 
position. (Figure 6) He underwent second 
stage transoral decompression after seven 
months following first surgery. 
Histopathological examination of specimen 
showed numerous osteoblastic giant cells, 
stroma shows oval to spindle cells and features 
were compatible with giant cell tumor and also 
received radiotherapy. He is doing well at last 
follow up after one year following initial 
surgery. 
 
 
Figure 1 - Computed tomography scan of cranio-
vertebral junction, sagittal section image, showing 
osteolytic lesion of vertebral body and fracture   lower 
endplate of axis vertebra 
 
 
 
 
 
Romanian Neurosurgery (2017) XXXI 3: 404 - 413 | 407 
 
 
 
 
 
 
 
 
Figure 2 - Coronal section,  computed tomographic 
scan of cranio-vertebral junction image of 38-year 
male with renal transplant  showing osteolytic lesion 
of vertebral body involving more to right side egg 
shell like preserved cortex     axis vertebra 
 
Figure 3 - Magnetic resonance imaging of   
Craniovertebral junction, Coronal section,  T1 
weighted image showing osteolytic lesion of vertebral 
body involving more to right side egg shell like 
preserved cortex axis vertebra 
 
Figure 4 - T1 weighted image   isointense lesion 
involving vertebral body of axis 
Magnetic resonance imaging of  Craniovertebral 
junction, sagittal section image showing mass causing 
compression of cervical cord 
 
 
Figure 5a - axial section T1 weighted image 
 
Figure 5b - axial  T2 weighted image 
Axial section Magnetic resonance imaging of   
Craniovertebral junction 
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Figure 6a - axial section image 
 
Figure 6b - sagittal section Craniovertebral junction 
CT scan 
Post-operative computed tomography scan, showing 
evidence of laminectomy with metallic artifact of 
implant in situ  
Discussion  
Giant cell tumour is commonly distributed 
in subarticular location with predilection for 
knee joint region, sacrum, distal radius and 
proximal radius, and those located in 
appendicular regions, usually remain centered 
in the epiphysis plate and extend eccentrically 
beyond epiphyseal boundary. (3, 4) However, 
vertebral column involvement is very rare 9 
and overall the cervical region localization 
accounts for less than 1% of overall occurrence 
of giant cell tumors. (4) 
Due to unpredictable behavior, in general 
only a third of total cases ultimately remain 
truly benign, while the rest two-third cases 
may progresses ultimately to either become 
locally invasive or may show metastasis to 
distant focus. In 1982, Fabiani et al (10) did a 
detailed review could collect a total of 66 cases 
PSPCT including their own two cases, which 
were located in the spinal column and 30 % 
occurred in cervical spine region, another 45 % 
in thoracic and 25% in lumbar region 
respectively.  
Giant cell tumor usually occurs in third or 
fourth decades of life, with a mean age of 27  
years and show slight female preponderances. 
Spinal GCT frequently presents with pain over 
the spinal column, progressive paraparesis or 
quadriparesis, however sphincter disturbance 
is less common. Authors in a detailed 
literature search of PSGCT involving Axis 
vertebra, could find only 12 primary case of 
PSGCT in the literature (4, 6, 9, 16, 17, 18, 22) 
(Table 1) and additional another two had 
recurrent GCT 8. (23)  
Radiograph may show selective 
involvement of vertebral body with soap-
bubble appearance associated with rarefaction 
and expansion of the vertebral body are 
important characteristic feature and may be 
helpful aid in preoperative diagnosis of the 
vertebral mass lesion and accordingly surgical 
intervention can be planned. 
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TABLE 1 
Review of primary giant cell tumor occurring in the Axis vertebra 
s.no. Author/ 
reference 
No. of 
cases 
Year  Age/ 
Sex 
Site of lesion stages of 
Surgical 
resection 
Surgical approach  
1. Honma et al.9 2 1989 
  
- Axis single Trans lingual and mandible splitting 
approach with fusion of spine from 
the atlas to the third cervical 
vertebra 
    - Axis Single   
2. Shirzadi et al. 6  1 2011 15-year/ 
male 
Odontoid process  Single stage 
surgery 
Initial Surgery 
3 Cebula et al.4 1 2012 - Body and lateral 
masses of axis vertebra 
- C2 giant cell tumor 
colonized by 
aneurysmal bone cyst 
Two stage  Preoperative embolization with two 
staged surgical intervention 
4. Hiromasa et al 16 1 2012 23-year/ 
Female 
- Body and vertebral 
arch of axis vertebra  
- cranial part of C3 
vertebra on posterior  
Two stage First - Posterior fusion with surgical 
resection and  
Second - Anterior approach spinal 
tumor extirpation and anterior 
fusion 
5 Chen et al. 18 5 2015 27-year/ 
Male 
Axis vertebra Two staged First – Posterior occipito-cervical 
fixation with 
Second- intralesional curettage 
    36-year/ 
Female 
Axis vertebra Two staged,  First- Posterior fixation  
Second stage - intra-lesional 
curettage 
    24-year 
/Female 
Axis vertebra Two stage  First - posterior occipito-cervical 
fixation  
Second - intra-lesional curettage 
    45-year 
/Female 
Axis vertebra Two stage  First - Posterior occipito-cervical 
fixation  
Second stage - Partial resection  
    23- Year 
/Male 
Axis vertebra Two stage  First - Posterior occipito-cervical 
fixation with  
2nd stage partial resection 
6 Mattei et al. 17 1 2014 22 -year/ 
Female 
 Vertebral body and 
odontoid process 
Non-surgical  Monotherapy with Denosumab 
monoclonal antibody designed to 
inhibit the receptor activator of 
nuclear factor kappa-B ligand led to 
long-term remission  
7 Bakhsh et al.22  2015 11–year/ 
Male  
Body and odontoid 
process  
Two staged 
surgery 
First - posterior decompression and 
posterior fixation, followed by 
anterior decompression and fixation 
 Current case 1 2017 38–year/ 
Male  
Body of axis and right 
lamina 
staged First - posterior decompression and 
posterior fixation, Second stage – 
transoral decompression 
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Computed tomography clearly delineates 
the extent of lesion, bony outline and spinal 
stability, involvement of foramen 
transeversarium and vertebral artery 
encasement. The CT angiography may better 
delineate the course of vertebral artery and 
delineates its relation to lesion. MRI spine is 
considered as investigation of choice and 
typically shows hypointense mass lesion on T1 
W image, and without significant alteration on 
T2 W image, also clearly delineates thecal sac 
and any spinal cord distortion as well as any 
associated co-existing intradural pathology or 
myelomalacia or cord signal alteration due to 
pressure effect. (4, 11) 
Histologically, the giant cell tumour is 
characterized by well vascularized lesion, 
uniformally composed of spindle or oval 
shaped undifferentiated stromal cellswith 
evenly dispersed numerous large 
multinucleated giant cells. (2, 3, 5) Stromal 
cells and evenly dispersed numerous giant cell 
resemble each other in regard to nuclei. 
However, the giant cell is also found in 
osteogenic sarcoma, chrondroblastoma, 
osteoblastoma, fibrous dysplasia, brown 
tumor and aneurysmal giant cell tumors. But 
distribution of giant cell may be either focally 
distributed or very few in number and giant 
cell size may be small and having few nuclei in 
these tumors. 
The natural history of PSGCT without 
treatment consist of enormous growth of 
tumor size, causing pressure effect on 
adjoining neurovascular structure leading to 
pathological fracture, malignant 
transformation and even distant metastasis. 
Management of GCT is surgical excision, 
however, wide surgical excision is not possible 
in cases of vertebral column lesion because of 
proximity to critical relation to spinal cords 
and vertebral artery in a single stage. (3, 5, 7) 
As single stage surgery involving anterior and 
posterior approaches produces significant 
alarming morbidity. (6, 9) The staged surgical 
approaches are devised and also used to ensure 
maximum resection of mass lesion with 
reduction in the morbidity. (4, 16, 17) All cases 
of PSGCT involving axis vertebra in literature 
were subjected for surgical resection (4, 6, 9, 
16, 17) except one reported by Mattei et al. al 
(18) without surgical intervention and he was 
managed with monoclonal antibody using 
Denosomab monotherapy. In the surgical 
group of PSGCT, eight cases underwent staged 
surgical procedure, first stage being posterior 
fixation followed by anterior approach in the 
second stage (4, 16, 17) current case was also 
managed in staged procedure. However, two 
cases, reported by Homnma et al. (9) 
underwent anterior bases approach utilizing 
translingual and mandible splitting route with 
fusion of spine extending from atlas to third 
cervical vertebra and one caes also reported by 
Shizardi et al. managed with single stage 
decompression surgery. (6) 
Cases with Giant cell tumor often show 
recurrence and there is wide range of variation 
depending upon the nature, route of surgical 
approaches, fixation, expertise of surgical team 
and extent of surgical decompression. About 
20-40 % recurrence rate is observed after 
simple curettage, however recurrence rate 
significantly decreases with more radical 
surgical procedure utilization followed by 
adjuvant therapy. In staged tumor resection 
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surgery, may provide better chances of radical 
decompression with appropriate fixation and 
further minimizing morbidity. (9) 
 If tumour recurs, further repeat biopsy of 
mass lesion is advisable to exclude recent 
malignant transformation, (8) followed by 
surgical resection and replacement of bone 
defects with suitable bone grafting and 
appropriate bony fixation which may prevent 
further recurrence. At recurrence, if the 
histopathological grading of tumour is higher, 
the lesion usually tends to invade vertebral 
body as well as posterior elements as compared 
to those confined to vertebral body alone (20 
% versus less than 6 %). (13) Periodic regular 
follow-up with detailed neurological 
examination with neuro imaging is 
recommended for five-years. (8)  
PSGCT is are generally considered 
histologically benign; however, can also 
exhibits locally aggressive behavior with a 
relatively high local rate recurrence of up to 
60%, if treated with curettage but it also carries 
the potential for distant metastasis, 
commonest to the lung, noted in upto 4% of 
cases. (19)  
 Bone and mineral disorder may occur 
frequently in renal transplant recipient and 
usually carry a high risk of bone fracture and 
associated morbidity. (20) A spectrum of a 
bone diseases are observed following the renal 
transplantation which may include 
osteoporosis. The pathophysiology of such 
bone disorders after transplantation results 
due to complex interplay of factors ie pre-
existing renal osteodystrophy, 
immunosuppression and alterations in the 
parathyroid hormone-vitamin D-fibroblast 
growth factor 23 axis and altered mineral 
metabolism. (20) 
 Alterations in the metabolism of calcium, 
phosphorus and magnesium minerals and 
parathyroid hormone, alkaline phosphatase, 
vitamin D and can have significant impact. 
Calcineurin inhibitors are linked to 
development of fresh osteoporosis, steroid 
therapy may cause additional osteoporosis and 
varying degrees of occurrence of the 
osteonecrosis. Immunosuppressant may 
impair osteoblast proliferation and 
differentiation Differentpharmacologic 
management are suggested withdrawal of 
steroid therapy, and supplementation of 
bisphosphonates, vitamin D derivatives, and 
denosumab are proposed. (21) 
PSGCT is locally invasive with variable is 
relatively a low radiosensitive tumor, so 
radiotherapy is usually reserved for surgically 
inaccessible or inoperable cases. However, 
radiation therapy also carries a risk of 
occurrence of high grade sarcoma in 
surrounding tissues. (13) Chemotherapy trial 
with Adriamycin has been tried for skull-base 
GCT. Recently Mattei et al. al (18), reported a 
22 year female managed primarily with 
monoclonal antibody using Denosomab 
without surgery.  
As surgical fixation in cases, with renal 
transplantation is double edges sword, as 
surgical resection without fixation may 
severely limit the extent of surgical resection 
and carry a chances of large residual. However, 
spinal fixation also carry risk of implant failure 
due to associated osteoporosis, continued 
therapy with steroid, immunosuppression 
medication. Author advocates a balanced 
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intervrention and tailored made therapy 
should be utilized for treatment in cases with 
PSGCT of Axis with renal transplantation and 
more frequent follow-up with neuroimaging 
to look for stability of implant and early 
detection of the tumor recurrence is highly 
important. 
Conclusion  
Early diagnosis and surgical management 
with spinal stabilization can help in preserving 
good neurological status, staged surgical 
procedure represents definitely a viable option 
for management of primary giant cell tumor 
affecting Axis vertebra. While dealing with 
osteolytic pathology of Axis vertebra, 
possibility of giant cell should also be 
considered despite rare occurrence as surgery 
can provide definitive surgical management 
along with adjuvant therapy and recently 
monoclonal antibody therapy is also showing 
promise for locally invasive and locally 
recurring primary lesion and neurosurgeons 
and radiologist must be aware of this 
pathology.  
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